Enterprise record
Alpha ID: alpha:company:a2b92c4d-4ab5-4d97-bea2-91da927acb21Version: public-1
27 published Claims7 sources
The enterprise, in context.
Connect capital, control, accountability, and evidence.
Governance priorities
Capital allocationInspect reported performance, cash generation, and investment.Board accountabilityWho holds each mandate, and what evidence supports it?Ownership & votingSeparate economic interests from voting authority.Key Claims
Board and committees
Financial statements
Published financial observations retain their reported values, periods, and sources. Coverage may be partial; this is not a reconstructed complete financial statement.
All financials coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageControl and shareholders
Control and shareholders coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageCompensation
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageAuditors, advisors and reporting
Auditors, advisors and reporting coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageLegal
AI governance
AI governance coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageEvidence, history and coverage
Additional published Claims
Published evidence records
7 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
Alpha canonical company public projection
canonical identity · Source published: Date unavailable · Retrieved: Oct 3, 2026
Supports 5 claims
- Legal Name: BIOGEN INC. · Claim reviewed: Oct 3, 2026
- Entity Status: Public listing published · Claim reviewed: Oct 3, 2026
- Published Fact: US · Claim reviewed: Oct 3, 2026
- Published Fact: DE · Claim reviewed: Oct 3, 2026
- Published Fact: Healthcare · Claim reviewed: Oct 3, 2026
BIOGEN INC. Form 10-K (filed 2026-02-06)
SEC filing · Source published: Date unavailable · Retrieved: Aug 29, 2026
Supports 2 claims
- Official Website: https://www.biogen.com · Claim reviewed: Oct 3, 2026
- Published Fact: https://www.biogen.com · Claim reviewed: Oct 3, 2026
BIIB 10-K executive officers
sec filing · Source published: Feb 6, 2026 · Retrieved: May 13, 2026
Supports 9 claims
- Leadership Role: Adam Keeney: Executive Vice President, Head of Corporate Development · Claim reviewed: Oct 3, 2026
- Leadership Role: Ginger Gregory: Executive Vice President and Chief Human Resources Officer · Claim reviewed: Oct 3, 2026
- Leadership Role: Jane Grogan: Executive Vice President, Head of Research · Claim reviewed: Oct 3, 2026
- Leadership Role: Nicole Murphy: Executive Vice President, Pharmaceutical Operations and Technology · Claim reviewed: Oct 3, 2026
- Leadership Role: Priya Singhal: Executive Vice President, Head of Development · Claim reviewed: Oct 3, 2026
- Leadership Role: Rachid Izzar: Executive Vice President, Global Product Strategy and Commercialization · Claim reviewed: Oct 3, 2026
- Leadership Role: Ronald J. Kramer: Executive Vice President and Chief Financial Officer · Claim reviewed: Oct 3, 2026
- Leadership Role: Sean Godbout: Vice President, Chief Accounting Officer and Global Corporate Controller · Claim reviewed: Oct 3, 2026
- Leadership Role: Susan H. Alexander: Executive Vice President, Chief Legal Officer · Claim reviewed: Oct 3, 2026
BIIB executive roster source
sec filing · Source published: May 3, 2026 · Retrieved: May 3, 2026
Supports 4 claims
- Leadership Role: Andrs Conesa Ph.D: Executive Vice President, Head of Corporate Development · Claim reviewed: Oct 3, 2026
- Leadership Role: George Mclean Milne Jr., Ph.D.: Executive Vice President and Chief Human Resources Officer · Claim reviewed: Oct 3, 2026
- Leadership Role: Jane Grogan, Ph.D.: Executive Vice President, Head of Research · Claim reviewed: Oct 3, 2026
- Leadership Role: Priya Singhal, M.D., M.P.H.: Executive Vice President, Head of Development · Claim reviewed: Oct 3, 2026
BIOGEN INC. DEF 14A 2026-04-28
sec proxy · Source published: Apr 28, 2026 · Retrieved: Apr 28, 2026
Supports 1 claim
- Leadership Role: Christopher A. Viehbacher: President and Chief Executive Officer · Claim reviewed: Oct 3, 2026
Audit
board seats · Source published: Date unavailable · Retrieved: Date unavailable
Supports 5 claims
- Committee Record: Audit: Chair William A. Hawkins; Members William A. Hawkins (Chair); Lloyd Minor; Monish Patolawala; Stephen A. Sherwin · Claim reviewed: Oct 3, 2026
- Committee Appointment: William A. Hawkins: chair, Audit · Claim reviewed: Oct 3, 2026
- Committee Appointment: Lloyd Minor: member, Audit · Claim reviewed: Oct 3, 2026
- Committee Appointment: Monish Patolawala: member, Audit · Claim reviewed: Oct 3, 2026
- Committee Appointment: Stephen A. Sherwin: member, Audit · Claim reviewed: Oct 3, 2026
S&P 500
index provider · Source published: Date unavailable · Retrieved: Sep 2, 2026
Supports 1 claim
- Index Membership: S&P 500 (SPX) · Claim reviewed: Oct 3, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-03
- Board and committees
- published
- Financial statements
- not observed
- Control and shareholders
- not observed
- Compensation
- not observed
- Auditors, advisors and reporting
- not observed
- Legal
- published
- AI governance
- not observed